Skip to main content
American Journal of Physiology - Lung Cellular and Molecular Physiology logoLink to American Journal of Physiology - Lung Cellular and Molecular Physiology
. 2009 Nov 6;298(2):L232–L242. doi: 10.1152/ajplung.00276.2009

Chronic hypoxia augments depolarization-induced Ca2+ sensitization in pulmonary vascular smooth muscle through superoxide-dependent stimulation of RhoA

Brad R S Broughton 1, Nikki L Jernigan 1, Charles E Norton 1, Benjimen R Walker 1, Thomas C Resta 1,
PMCID: PMC2822557  PMID: 19897743

Abstract

Rho kinase (ROCK)-dependent vasoconstriction has been implicated as a major factor in chronic hypoxia (CH)-induced pulmonary hypertension. This component of pulmonary hypertension is associated with arterial myogenicity and increased vasoreactivity to receptor-mediated agonists and depolarizing stimuli resulting from ROCK-dependent myofilament Ca2+ sensitization. On the basis of separate lines of evidence that CH increases pulmonary arterial superoxide (O2) generation and that O2 stimulates RhoA/ROCK signaling in vascular smooth muscle (VSM), we hypothesized that depolarization-induced O2 generation mediates enhanced RhoA-dependent Ca2+ sensitization in pulmonary VSM following CH. To test this hypothesis, we determined effects of the ROCK inhibitor HA-1077 and the O2-specific spin trap tiron on vasoconstrictor reactivity to depolarizing concentrations of KCl in isolated lungs and Ca2+-permeabilized, pressurized small pulmonary arteries from control and CH (4 wk at 0.5 atm) rats. Using the same vessel preparation, we examined effects of CH on KCl-dependent VSM membrane depolarization and O2 generation using sharp electrodes and the fluorescent indicator dihydroethidium, respectively. Finally, using a RhoA-GTP pull-down assay, we investigated the contribution of O2 to depolarization-induced RhoA activation. We found that CH augmented KCl-dependent vasoconstriction through a Ca2+ sensitization mechanism that was inhibited by HA-1077 and tiron. Furthermore, CH caused VSM membrane depolarization that persisted with increasing concentrations of KCl, enhanced KCl-induced O2 generation, and augmented depolarization-dependent RhoA activation in a O2-dependent manner. These findings reveal a novel mechanistic link between VSM membrane depolarization, O2 generation, and RhoA activation that mediates enhanced myofilament Ca2+ sensitization and pulmonary vasoconstriction following CH.

Keywords: pulmonary hypertension, Rho kinase, membrane potential


chronic hypoxia (CH) associated with high-altitude exposure and chronic obstructive pulmonary disease leads to elevated pulmonary vascular resistance and pulmonary hypertension. The vasoconstrictor component of CH-induced pulmonary hypertension is mediated, in part, by generalized hypoxic pulmonary vasoconstriction resulting from global airway hypoxia. However, hypoxic vasoreactivity is largely blunted following CH (31), suggesting that additional mechanisms provide a major contribution to the development of pulmonary hypertension. Findings that basal tone is elevated in pulmonary arterial rings from CH rats (34, 54) and that vasodilators substantially lower pulmonary vascular resistance in CH rats acutely returned to a normoxic environment (34) provide further evidence that the vasoconstrictor response to CH is multifaceted and a primary determinant of pulmonary hypertension. Consistent with these findings, recent studies from our laboratory and others have identified an effect of CH on induction of myogenic tone in small pulmonary arteries (3) and enhancement of agonist-dependent vasoconstriction through a RhoA/Rho kinase (ROCK)-mediated myofilament Ca2+ sensitization pathway (14, 20, 34, 54), responses that may contribute to the pathogenesis of pulmonary hypertension in this setting.

RhoA is a small GTP-binding protein that is activated in response to stimulation of many G protein-coupled receptors (45). However, RhoA-mediated vascular smooth muscle (VSM) Ca2+ sensitization can also be elicited by depolarizing stimuli (33, 41, 50, 55). Membrane potential (Em) depolarization-induced VSM contraction appears to be mediated, in part, via Ca2+-dependent stimulation of RhoA/ROCK (33, 41, 50, 55), thus establishing a dual role for Ca2+ in regulation of VSM contraction: 1) activation of myosin light chain (MLC) kinase and 2) RhoA-mediated inhibition of MLC phosphatase. Interestingly, depolarization has been demonstrated to stimulate RhoA via a Ca2+-independent mechanism in renal tubule epithelial cells (46). Whether a similar mechanism of RhoA activation exists in VSM and whether such a mechanism contributes to enhanced depolarization-induced pulmonary vasoconstriction following exposure to CH (2, 14, 34) have not been addressed. On the basis of evidence that exogenous reactive oxygen species (ROS), including superoxide anion (O2), mediate ROCK-dependent VSM contraction (21, 22, 24) and that Em depolarization increases ROS production in endothelial cells, macula densa, and isolated lungs (1, 28, 44), we hypothesized that depolarization-induced O2 generation mediates enhanced RhoA-dependent Ca2+ sensitization in pulmonary VSM following CH. This hypothesis was tested by assessment of depolarization-dependent vasoconstriction, VSM-free intracellular Ca2+ concentration ([Ca2+]i), O2 generation, and Em in pressurized, small pulmonary arteries from normoxic and CH rats. We additionally evaluated the contribution of O2 to depolarization-induced RhoA activation in intrapulmonary arteries and vasoreactivity in isolated perfused lungs from each group. Our findings demonstrate a unique mechanistic relationship between Em depolarization, O2 generation, and RhoA/ROCK signaling that mediates increased myofilament Ca2+ sensitivity in the hypertensive pulmonary circulation.

MATERIALS AND METHODS

All protocols and surgical procedures were reviewed and approved by the Institutional Animal Care and Use Committee of the University of New Mexico Health Sciences Center.

Experimental Groups

Male Sprague-Dawley rats (250–300 g body wt; Harlan Industries) were exposed to CH by placement in a hypobaric chamber maintained at ∼380 Torr for 4 wk, as previously described (3, 20, 35, 39).

Isolated Lung Protocols: Contribution of ROCK and O2 to KCl-Dependent Vasoconstriction

The following protocols were performed to determine the contribution of ROCK and O2 to depolarization-mediated pulmonary vasoconstriction in lungs from control and CH rats. Lungs were isolated from rats, perfused with a physiological salt solution (PSS) containing (in mmol/l) 129.8 NaCl, 5.4 KCl, 0.5 NaH2PO4, 0.83 MgSO4, 19 NaHCO3, 1.8 CaCl2, and 5.5 glucose, with 4% bovine serum albumin (wt/vol) added as a colloid (all from Sigma), and prepared for experimentation using established procedures (18, 38, 39, 52). After stabilization of baseline pressures, we assessed a cumulative concentration-response relationship to KCl in lungs from control and CH rats by switching the perfusate to PSS containing depolarizing concentrations of KCl (15–60 mmol/l). This PSS had the same osmolality as the control solution and is identical in composition, except it contained more KCl and less NaCl than normal PSS. All experiments were conducted in the presence of the ROCK inhibitor HA-1077 (10 μmol/l; Sigma) (3, 5), the O2-specific spin trap 4,5-dihydroxy-1,3-benzene disulfonic acid (tiron, 10 mmol/l; Sigma) (18, 20, 25), or vehicle (PSS). To eliminate influences of endogenous nitric oxide (NO) and cyclooxygenase (COX) products on depolarization-dependent vasoconstriction, we conducted parallel experiments after administration of the NO synthase inhibitor Nω-nitro-l-arginine (l-NNA, 300 μmol/l; Sigma) and the COX inhibitor meclofenamate (160 μmol/l; Sigma). These concentrations of l-NNA and meclofenamate have been shown to effectively inhibit NO and prostaglandin synthesis in this preparation (10, 52).

Isolated Small Pulmonary Artery Preparation: Assessment of Vasoreactivity, VSM [Ca2+]i, Em, and O2 Levels

Endothelial disruption and cannulation of small pulmonary arteries for dimensional analysis.

Rats were anesthetized with pentobarbital sodium (200 mg/kg ip), and the left lung was removed and immediately placed in ice-cold PSS. A pulmonary artery [100–200 μm internal diameter (ID), ∼1 mm long] without side branches was dissected free and transferred to a vessel chamber (model CH-1, Living Systems) containing cold PSS. After the proximal end of the vessel was cannulated with a tapered glass pipette and blood was flushed out, the vessel lumen was rubbed with a strand of moose mane to disrupt the endothelium, thereby allowing assessment of depolarization-induced myofilament Ca2+ sensitization independent of complicating influences of the endothelium. Arteries were then cannulated at the distal end and pressurized to 12 or 35 Torr using a servo-controlled peristaltic pump (Living Systems). These pressures are estimates of in vivo pressures in conscious rats from each group, as determined previously (38). Arteries were required to hold a steady pressure when the servo-control function was switched off to verify the absence of leaks. Any vessels with apparent leaks were discarded. The vessel chamber was transferred to the stage of a Nikon Eclipse TS100 microscope, and the preparation was superfused with PSS (37°C) equilibrated with 10% O2-6% CO2-balance N2. A vessel chamber cover was positioned to permit this same gas mixture to flow over the top of the chamber bath. This gas mixture yields an approximate superfusate pH 7.40, 57 Torr Po2, and 31 Torr Pco2 (18). Bright-field images of vessels were obtained with a charge-coupled device camera (model CCD100M, IonOptix), and dimensional analysis was performed by IonOptix Sarclen software to measure ID. The effectiveness of endothelial disruption was verified by the lack of a vasodilatory response to ACh (1 μmol/l) in UTP-constricted vessels. These methods have been described in previous studies from our laboratory (3, 7, 19, 20, 35).

Measurement of VSM [Ca2+]i.

Pressurized, endothelium-disrupted arteries were loaded abluminally with the cell-permeant, ratiometric, Ca2+-sensitive fluorescent indicator fura 2-AM (2 μmol/l fura 2-AM + 0.05% pluronic acid; Molecular Probes) for 45 min at room temperature in darkness, as described previously (3, 7, 19, 20, 35). Vessels were rinsed for 20 min with PSS (37°C; equilibrated with 10% O2-6% CO2) after the loading period to wash out excess dye and to allow for hydrolysis of acetoxymethyl groups by intracellular esterases. Fura 2-loaded arteries were alternately excited at 340 and 380 nm at a frequency of 10 Hz with an IonOptix Hyperswitch dual-excitation light source, and the respective 510-nm emissions were collected with a photomultiplier tube. Background-subtracted ratio of emission at 340 nm to emission at 380 nm was calculated with IonOptix Ion Wizard software and recorded continuously throughout the experiment, with simultaneous measurement of ID from red-wavelength bright-field images, as described above. VSM [Ca2+]i is expressed as the mean ratio of fluorescence at 340 nm to fluorescence at 380 nm (F340/F380) from the background-subtracted 510-nm signal.

VSM Ca2+ permeabilization.

To directly assess mechanisms of myofilament Ca2+ sensitization independent of changes in VSM [Ca2+]i, we clamped VSM [Ca2+]i in some experiments by permeabilization with the Ca2+ ionophore ionomycin, as previously described (19, 20). Briefly, arteries were equilibrated in Ca2+-free PSS containing 3 mmol/l EGTA (Sigma) and 3 μmol/l ionomycin (Sigma) to permeabilize the VSM to Ca2+. Vessels were then equilibrated in PSS with a calculated free Ca2+ concentration of 300 nmol/l [containing (in mmol/l) 129.8 NaCl, 5.4 KCl, 0.5 NaH2PO4, 1.3 MgSO4, 19 NaHCO3, 6.8 CaCl2, 5.5 glucose, 8.2 EGTA, and 0.003 ionomycin (Sigma)]. This Ca2+ concentration was calculated using the Kd of EGTA for Ca2+ of 43.7 nmol/l and the Kd of EGTA for Mg2+ of 3.33 mmol/l at 37°C and pH 7.4, as described previously (19, 20). The addition of 300 nmol/l Ca2+-containing PSS provided optimal vasoconstrictor responses to KCl with minimal effects on basal tone in Ca2+-permeabilized arteries in preliminary experiments.

Measurement of VSM Em.

VSM cell Em values were recorded using intracellular sharp electrodes from pressurized, endothelium-disrupted, Ca2+-permeabilized pulmonary arteries from control and CH rats prepared as described above. VSM cells were impaled with microelectrodes (50- to 100-MΩ tip resistance) containing 1 M KCl and filled with Lucifer Yellow dye (Sigma) for subsequent identification of cell type. A Neuroprobe amplifier (model 1600, A-M Systems) was used to record Em. Analog output from the amplifier was low-pass filtered at 1 kHz and routed to a Tektronix RM502A oscilloscope and a data acquisition system (Dataq Instruments). Criteria for acceptance of Em recordings were as follows: 1) an abrupt negative deflection in potential as the microelectrode is advanced into the cell, 2) stable Em for ≥1 min, and 3) an abrupt change in potential to ∼0 mV after the electrode is retracted from the cell. After completion of Em recordings, fluorescent imaging of dye-loaded cells was used to verify the cell type for each recording. The mean Em of all VSM cells recorded for an individual rat was considered a single replicate for statistical purposes. We described these methods in earlier studies (7, 35).

Measurement of O2.

Fluorescence detection of dihydroethidium (DHE; Molecular Probes) oxidation was used as a measure of O2 levels in pressurized, endothelium-disrupted, Ca2+-permeabilized arteries from control and CH rats, as reported previously (20). Cells are permeable to DHE, which is converted to the fluorescent products ethidium and 2-hydroxyethidium in an O2-dependent manner (6, 57). Arteries were prepared for experimentation as described above and transferred to the stage of a Nikon Diaphot microscope. After 30 min of equilibration, arteries were loaded with DHE (10 μmol/l DHE and 0.05% pluronic acid). Vessels were incubated in this solution for 30 min at room temperature in darkness and then rinsed for 5 min with PSS (37°C) to wash out excess dye. We obtained fluorescent images using a standard tetramethylrhodamine isothiocyanate filter before (for background subtraction) and after loading the vessel with DHE. Images (1 per minute) were generated with a charge-coupled device camera (Photometrics SenSys 1400) and processed with MetaFluor software (Molecular Devices). Normalized fluorescence intensity is defined as average gray-scale values for all pixels in the field above background.

Experimental Protocols Assessing Vasoreactivity, VSM [Ca2+]i, Em, and O2 Levels in Pressurized Small Pulmonary Arteries

KCl-induced vasoconstrictor and VSM [Ca2+]i responses in nonpermeabilized arteries: role of ROCK.

To characterize effects of CH on depolarization-mediated vasoconstriction and the contribution of ROCK to this response, we assessed ID and VSM [Ca2+]i responses to depolarizing concentrations of KCl (30–120 mmol/l) in nonpermeabilized arteries from control and CH rats in the presence or absence of the selective ROCK inhibitor HA-1077 (10 μmol/l) (3, 5, 26, 40, 49).

Role of ROCK, PKC, L-type Ca2+ channels, and O2 in KCl-dependent VSM Ca2+ sensitization.

The contribution of ROCK to KCl-induced myofilament Ca2+ sensitization was established by measurement of vasoconstrictor responses to increasing concentrations of KCl in the presence of HA-1077 (10 μmol/l) or vehicle (PSS) in Ca2+-permeabilized control and CH arteries. F340/F380 values were measured continuously to verify that VSM [Ca2+]i remained clamped for the duration of the experiment.

Since VSM Ca2+ sensitization can additionally be mediated by PKC (19), we assessed responses to KCl in separate sets of Ca2+-clamped arteries from each group after administration of the broad-spectrum PKC inhibitor GF-109203X (1 μmol/l; Biomol) (3, 19, 47) or vehicle (dimethylsulfoxide). We previously reported that these concentrations of HA-1077 (3) and GF-109203X (3, 19) selectively inhibit ROCK and PKC, respectively, in this preparation.

To verify that L-type Ca2+ channels do not contribute to KCl-induced constriction in Ca2+-permeabilized arteries, parallel experiments were conducted in arteries pretreated with the L-type Ca2+ channel inhibitor diltiazem (50 μmol/l) or vehicle (PSS). This concentration of diltiazem inhibits KCl-mediated increases in VSM [Ca2+]i in this preparation (17).

The role of O2 in mediating KCl-dependent Ca2+ sensitization was determined in Ca2+-permeabilized small pulmonary arteries from control and CH rats. Vasoconstrictor responses to increasing concentrations of KCl (30–120 mmol/l) were assessed in arteries in the presence of the O2 scavenger tiron (10 mmol/l; Sigma), a combination of tiron and HA-1077 (10 mmol/l and 10 μmol/l, respectively), or vehicle (PSS). This concentration of tiron inhibits xanthine oxidase-induced ROS generation in isolated pulmonary arteries, as determined in previous studies by our laboratory (18).

Effects of CH and ROCK inhibition on basal VSM Em and KCl-mediated depolarization.

These experiments were performed to determine whether pulmonary VSM Em is persistently depolarized in CH arteries compared with control vessels after administration of depolarizing concentrations of KCl and to assess potential influences of HA-1077 on basal Em. The endothelium of arteries from each group was disrupted, pressurized, permeabilized to Ca2+, and prepared for experimentation as described above. VSM Em was assessed using sharp electrodes under basal conditions and after administration of KCl (30 and 60 mmol/l). Basal VSM Em was measured in the presence or absence of HA-1077 (10 μmol/l) in similar experiments.

Effects of CH and ROCK inhibition on KCl-induced O2 generation.

To assess the association between depolarization-induced RhoA/ROCK signaling and O2 levels, we evaluated the effects of KCl on DHE oxidation products by fluorescence microscopy as a measure of O2 generation in Ca2+-permeabilized arteries from control and CH rats. After washout of DHE, KCl (60 mmol/l) was added to the superfusate, and DHE fluorescence was measured over a 12-min period. In separate experiments, vessels were pretreated with tiron (10 mmol/l) before administration of KCl to verify the contribution of O2 to the fluorescent signal. In parallel protocols, we measured KCl-induced changes in DHE fluorescence intensity after administration of HA-1077 (10 μmol/l) or vehicle in arteries from CH rats.

Western Blotting: Effects of CH and O2 on Depolarization-Mediated RhoA Activation

Intrapulmonary arteries from control and CH rats were dissected from accompanying airways and surrounding lung tissue in a HEPES-based PSS containing (in mmol/l) 130 NaCl, 4 KCl, 1.2 MgSO4, 4 NaHCO3, 1.8 CaCl2, 10 HEPES, 1.18 KH2PO4, 6 glucose, and 0.03 EDTA, with pH adjusted to 7.4 with NaOH. Arteries were incubated at 37°C for 30 min with ionomycin (3 μmol/l) to clamp VSM [Ca2+]i, stimulated with KCl (60 mmol/l) or vehicle for 5 min, and then snap-frozen in liquid N2. Separate sets of arteries were treated with KCl (60 mmol/l) in the presence of tiron (10 mmol/l) or vehicle for analysis of O2-dependent activation of RhoA. Each sample was homogenized in 10 mmol/l Tris·HCl homogenization buffer containing 255 mmol/l sucrose, 2 mmol/l EDTA, 12 μmol/l leupeptin, 1 μmol/l pepstatin A, 0.3 μmol/l aprotinin, and 1 mmol/l phenylmethylsulfonyl fluoride (Sigma). Samples were centrifuged at 10,000 g for 10 min at 4°C to remove insoluble debris. The supernatant was collected, and sample protein concentrations were determined by the Bradford method (Bio-Rad Protein Assay). RhoA activity was assessed using a Rho activation assay kit (Cytoskeleton) that detects levels of GTP-bound RhoA, as previously reported (19, 20). Levels of GTP-bound RhoA were normalized to levels of total RhoA protein determined from separate Western blots (25 μg/lane).

Calculations and Statistics

Pulmonary vascular resistance in isolated lung studies was calculated as the difference between arterial and venous pressure divided by flow. Vasoconstrictor responses to KCl were calculated as a change in resistance from baseline. Vasoconstrictor responses in isolated arteries were calculated as a percentage of baseline ID. VSM [Ca2+]i is represented as ratio of emission at 340 nm to emission at 380 nm for fura 2 (F340/F380). GTP-bound RhoA was normalized to total RhoA expression for each sample. Values are means ± SE; n refers to the number of animals in each group. A t-test, two-way ANOVA, or two-way repeated-measures ANOVA was used to make comparisons when appropriate. If differences were detected by ANOVA, individual groups were compared with the Student-Newman-Keuls test. P < 0.05 was accepted as significant for all comparisons.

RESULTS

CH rats exhibited polycythemia, as indicated by a significantly greater hematocrit (66.2 ± 0.4%, n = 28) than in normoxic control rats (45.8 ± 0.5%, n = 29). This model of CH additionally produces many other cardiopulmonary changes observed in chronic obstructive pulmonary disease and prolonged residence at high altitude, including right ventricular hypertrophy, pulmonary hypertension, and arterial remodeling (38).

CH Enhances Depolarization-Induced Vasoconstriction in Isolated Lungs but Attenuates the VSM [Ca2+]i Response to KCl in Small Pulmonary Arteries

Basal vascular resistances were significantly elevated in lungs isolated from CH rats compared with normoxic controls (see supplemental Table 1S in the online version of this article), as previously reported (38). Vasoconstrictor responses to KCl were greater in isolated, saline-perfused lungs from CH rats than in control lungs (Fig. 1A). Because pulmonary vasoreactivity to KCl may be modified by endothelial factors, we additionally examined vasoconstriction to KCl in isolated lungs pretreated with the NO synthase inhibitor l-NNA and the COX inhibitor meclofenamate. Similar to effects of CH in untreated lungs, vasoconstrictor responses to KCl were greater in lungs from CH than control rats after combined NO synthase and COX inhibition (see supplemental Fig. 1S).

Fig. 1.

Fig. 1.

Chronic hypoxia (CH) increases vasoconstriction to depolarizing concentrations of KCl in isolated rat lungs (A) but attenuates KCl-mediated increases in vascular smooth muscle (VSM) intracellular Ca2+ concentration ([Ca2+]i) in small pulmonary arteries (B). A: effect of increasing concentrations of KCl (15–60 mmol/l) on resistance (Torr·ml−1·min·kg body wt−1) in isolated, saline-perfused lungs from normoxic control (n = 4) and CH (n = 4) rats. B: vasoconstrictor [percent baseline internal diameter (ID); top] and VSM [Ca2+]i [ratio of emission at 340 nm to emission at 380 nm for fura 2 (F340/F380); bottom] responses to KCl (30–120 mmol/l) in endothelium-disrupted, small pulmonary arteries from control (n = 4) and CH (n = 4) rats. Values are means ± SE. *P < 0.05 vs. control.

To assess effects of CH on VSM reactivity and Ca2+ mobilization in response to a depolarizing stimulus, we additionally performed concentration-response curves to KCl in fura 2-loaded small pulmonary arteries from each group. All arteries in these and subsequent protocols were studied at 12 Torr transmural pressure, unless otherwise noted, and the endothelium was disrupted to eliminate influences of endothelium-derived factors on depolarization-induced intracellular Ca2+ mobilization and vasoconstriction. Basal ID and VSM [Ca2+]i were similar between groups (see supplemental Table 2S). VSM [Ca2+]i responses to KCl were markedly blunted in arteries from CH rats compared with controls, despite similar or moderately increased vasoconstriction in CH arteries (Fig. 1B), indicating that CH increases depolarization-induced VSM Ca2+ sensitization.

CH Augments Em Depolarization-Induced Vasoconstriction Independent of Changes in VSM [Ca2+]i

In further experiments, we assessed concentration-response relationships to KCl in arteries in which VSM [Ca2+]i had been clamped using the Ca2+ ionophore ionomycin to directly evaluate whether CH augments depolarization-induced myofilament Ca2+ sensitization through a Ca2+-independent signaling pathway. Figure 2A depicts traces of ID and the ratio of emission at 340 nm to emission at 380 nm vs. increasing concentrations of KCl from a Ca2+-permeabilized CH artery. Switching from superfusion with Ca2+-free PSS to PSS containing 300 nmol/l Ca2+ produced an increase in VSM [Ca2+]i [from 0.576 ± 0.035 (control, n = 34) to 0.609 ± 0.027 (CH, n = 33)] and a modest vasoconstriction [18.7 ± 3.2% (control, n = 34) and 20.6 ± 2.5% (CH, n = 33)], resulting in similar ID and [Ca2+]i between groups (see supplemental Table 2S). After stabilization of vessel ID and VSM [Ca2+]i, a concentration-response curve to KCl was performed. Interestingly, KCl caused constriction without increasing VSM [Ca2+]i (Fig. 2, A and B), thus providing direct evidence that Em depolarization mediates vasoconstriction in hypertensive pulmonary arteries through a Ca2+-independent signaling mechanism. Consistent with enhancement of myofilament Ca2+ sensitivity in nonpermeabilized arteries by CH (Fig. 1B), KCl-induced constriction was greater in CH than control arteries (Fig. 2B, top), whereas VSM [Ca2+]i remained stable in both groups (Fig. 2B, bottom). Similar results were obtained from arteries pressurized to 35 Torr (see supplemental Fig. 2S).

Fig. 2.

Fig. 2.

CH augments depolarization-induced VSM Ca2+ sensitization in Ca2+-permeabilized arteries. A: traces of ID (top) and VSM [Ca2+]i (bottom) in an endothelium-disrupted artery from a CH rat after permeabilization to Ca2+ with ionomycin (3 μmol/l). Switching from superfusion with Ca2+-free physiological saline solution (PSS) to PSS containing 300 nmol/l Ca2+ caused an increase in F340/F380 and a slight constriction. Addition of KCl (30–120 mmol/l) resulted in vasoconstriction without a change in VSM [Ca2+]i. B: percent vasoconstriction and VSM [Ca2+]i responses to KCl in Ca2+-permeabilized arteries from control (n = 5) and CH (n = 5) rats. Values are means ± SE. *P < 0.05 vs. control.

Increased Depolarization-Induced VSM Ca2+ Sensitization Following CH Is Dependent on ROCK, but not PKC or L-Type Ca2+ Channels

Because depolarization stimulates RhoA/ROCK signaling independent of changes in [Ca2+]i in renal tubular epithelium (46), we next evaluated the contribution of ROCK to KCl-induced vasoconstriction in isolated lungs and nonpermeabilized arteries. Whereas the selective ROCK inhibitor HA-1077 modestly attenuated reactivity to KCl in control lungs, vasoconstriction was nearly abolished after ROCK inhibition in lungs from CH rats (Fig. 3A). Parallel responses to ROCK inhibition were noted in l-NNA- and meclofenamate-pretreated lungs from each group (see supplemental Fig. 1S).

Fig. 3.

Fig. 3.

Depolarization-induced vasoconstriction is Rho kinase (ROCK)-dependent in isolated lungs (A) and nonpermeabilized arteries (B) from CH rats. A: changes in resistance to KCl (15–60 mmol/l) in isolated, perfused lungs from control and CH rats in the presence of the ROCK inhibitor HA-1077 (10 μmol/l) or vehicle (n = 4 per group for each treatment). B: percent vasoconstriction to KCl (30–120 mmol/l) in endothelium-disrupted arteries from control and CH rats in the presence of HA-1077 (10 μmol/l) or vehicle (n = 4–5 per group for each treatment). Values are means ± SE. *P < 0.05 vs. control vehicle. #P < 0.05 vs. corresponding vehicle.

A similar inhibitory influence of HA-1077 on depolarization-induced vasoconstriction was demonstrated in nonpermeabilized arteries from CH rats (Fig. 3B), although considerable VSM tone remained after ROCK inhibition. Furthermore, in contrast to the response to ROCK inhibition in isolated lungs (Fig. 3A), HA-1077 had no effect on reactivity to KCl in arteries from control rats. These findings support a pivotal role for ROCK in mediating enhanced KCl-mediated vasoconstriction in the hypertensive pulmonary circulation.

To determine the contribution of ROCK and PKC to increased depolarization-induced VSM Ca2+ sensitization following CH, we examined effects of HA-1077 or the broad-spectrum PKC antagonist GF-109203X (30, 47) on KCl-mediated vasoconstriction in Ca2+-clamped arteries. In previous studies, we verified the efficacy and specificity of GF-109203X for PKC vs. ROCK in this preparation (3, 20). HA-1077 significantly attenuated vasoconstrictor responses to KCl only in arteries from CH rats (Fig. 4A), effectively normalizing reactivity to that of control arteries. In contrast, GF-109203X did not alter constriction to KCl in arteries from control or CH rats (Fig. 4B), suggesting that PKC does not contribute to enhanced depolarization-induced VSM Ca2+ sensitization following CH. As expected in Ca2+-clamped arteries, blockade of L-type Ca2+ channels with diltiazem was also without effect on vasoconstriction to KCl in both groups (Fig. 4C).

Fig. 4.

Fig. 4.

Enhanced depolarization-induced VSM Ca2+ sensitization following CH is dependent on ROCK, but not PKC or L-type Ca2+ channels, in Ca2+-permeabilized arteries. Vasoconstriction to KCl (30–120 mmol/l) in Ca2+-permeabilized, endothelium-disrupted arteries from control and CH rats in the presence of HA-1077 (10 μmol/l; A), the broad-spectrum PKC inhibitor GF-109203X (1 μmol/l; B), the L-type Ca2+ channel antagonist diltiazem (50 μmol/l; C), or vehicle (n = 5 per group for each treatment). Values are means ± SE. *P < 0.05, CH vehicle vs. control vehicle. #P < 0.05, CH HA-1077 vs. CH vehicle.

VSM Em Is Depolarized in CH Compared With Control Arteries, and This Separation of Em Persists After Exposure to Depolarizing Concentrations of KCl

VSM cell basal Em was depolarized in pressurized, Ca2+-permeabilized small pulmonary arteries from CH animals relative to control vessels, as previously reported in nonpermeabilized arteries (Fig. 5A) (35). Furthermore, this separation of VSM Em between control and CH vessels was maintained during exposure to depolarizing concentrations of KCl.

Fig. 5.

Fig. 5.

CH-induced pulmonary VSM membrane potential (Em) depolarization persists on exposure to depolarizing concentrations of KCl (A) and is unaltered by ROCK inhibition (B) in Ca2+-permeabilized arteries. A: VSM Em responses to increasing concentrations of KCl [5.4 (basal), 30, and 60 mmol/l] in pressurized, endothelium-disrupted, Ca2+-permeabilized arteries from control and CH rats (n = 4 per group at each KCl concentration). B: VSM Em in arteries from control and CH rats prepared as described in A and treated with HA-1077 (10 μmol/l) or vehicle (n = 3 per group for each treatment). Values are means ± SE. *P < 0.05 vs. control. #P < 0.05 vs. basal. †P < 0.05 vs. 30 mM KCl.

VSM Cell Em Is Unaltered by ROCK Inhibition

Although ROCK has been reported to cause VSM Em depolarization through inhibition of voltage-sensitive K+ channels (29), we observed no effect of HA-1077 on VSM Em in pressurized, Ca2+-permeabilized pulmonary arteries from either group (Fig. 5B). These data suggest that inhibitory effects of HA-1077 on KCl-induced Ca2+ sensitization are not related to alterations in Em.

CH Augments Depolarization-Induced RhoA Activation in Pulmonary Arteries

To determine whether RhoA activation induces depolarization-dependent ROCK signaling in pulmonary arteries from CH rats, we assessed effects of KCl (60 mmol/l) on levels of GTP-bound (activated) RhoA in Ca2+-permeabilized pulmonary arteries from control and CH rats. Total RhoA expression was unaltered by CH (Fig. 6A), as demonstrated previously (20). Although we observed a tendency for CH to elevate basal RhoA activity, as described in earlier studies (20), this did not achieve statistical significance (Fig. 6B). Consistent with vasoactive responses to KCl in pressurized arteries (Fig. 4A), KCl increased GTP-bound RhoA levels in arteries from CH, but not control, rats (Fig. 6B). Because VSM [Ca2+]i was clamped in these experiments, our results demonstrate that depolarization stimulates RhoA through a Ca2+-independent signaling pathway in arteries from pulmonary hypertensive rats.

Fig. 6.

Fig. 6.

CH augments depolarization-induced pulmonary arterial RhoA activation but does not alter RhoA expression. A: mean densitometric data for total RhoA normalized to Coomassie-stained total protein in homogenates of intrapulmonary arteries from control (n = 14) and CH (n = 15) rats. B: mean densitometric data for activated (GTP-bound) RhoA normalized to total RhoA in homogenates of Ca2+-permeabilized intrapulmonary arteries from control (n = 7 per group for each treatment) and CH (n = 7–8 per group for each treatment) rats under basal conditions (5.4 mmol/l KCl) or in response to 60 mmol/l KCl. Values are means ± SE. *P < 0.05 vs. control KCl. #P < 0.05 vs. CH basal.

O2 Mediates Enhanced Depolarization-Induced VSM Ca2+ Sensitization Following CH

Since CH increases pulmonary arterial O2 generation (11, 20, 27, 56) and O2 has been implicated in RhoA activation in the systemic (21, 22) and pulmonary (20, 24) circulations, we next used isolated lungs and Ca2+-clamped pulmonary arteries to examine whether O2 mediates CH-induced increases in vasoreactivity to KCl. Consistent with this possibility, the O2-specific spin trap tiron attenuated vasoconstriction to KCl in isolated lungs from CH, but not control, animals, thus normalizing reactivity between groups (Fig. 7A).

Fig. 7.

Fig. 7.

O2 mediates increased KCl-induced vasoconstriction and associated VSM Ca2+ sensitization following CH in isolated perfused lungs (A) and Ca2+-permeabilized arteries (B and C). A: changes in resistance to KCl (15–60 mmol/l) in isolated, perfused lungs from control and CH rats in the presence of the O2-specific spin trap tiron (10 mmol/l) or vehicle (n = 5 per group for each treatment). B and C: vasoconstrictor responses to KCl (30–120 mmol/l) in Ca2+-permeabilized, endothelium-disrupted arteries from control (n = 5 per treatment; B) and CH (n = 5 per treatment; C) rats in the presence of tiron (10 mmol/l), tiron + HA-1077 (10 μmol/l), or vehicle. Values are means ± SE. *P < 0.05 vs. control vehicle. #P < 0.05, CH tiron and CH tiron + HA-1077 vs. CH vehicle.

Similar to effects of ROCK inhibition (Fig. 4A), tiron significantly inhibited KCl-mediated vasoconstriction in Ca2+-permeabilized CH arteries, but not control vessels (Fig. 7, B and C). However, the combination of tiron and HA-1077 did not provide greater attenuation of KCl-dependent reactivity than scavenging of O2 alone, again resulting in similar vasoconstriction between groups.

CH Increases Basal and KCl-Stimulated O2 Levels in Pressurized Pulmonary Arteries

Basal DHE fluorescence was significantly greater in pressurized, Ca2+-permeabilized arteries from CH rats than controls (Fig. 8, A and B). Interestingly, KCl (60 mmol/l) markedly increased DHE fluorescence in arteries from CH rats but had no effect in control vessels. As expected, tiron abolished the CH-induced elevation of basal and KCl-stimulated O2 production without altering DHE fluorescence in arteries from normoxic rats. Control experiments revealed no time-dependent changes in fluorescence in CH arteries (see supplemental Fig. 3SA). ROCK inhibition with HA-1077 had no effect on basal or KCl-induced O2 generation in CH arteries (see supplemental Fig. 3SB), which argues against a potential role for ROCK in enhancement of basal O2 levels or depolarization-dependent Ca2+ sensitization through stimulated O2 production.

Fig. 8.

Fig. 8.

CH increases basal and KCl-stimulated O2 levels in Ca2+-permeabilized arteries (A and B). O2 mediates CH-induced increases in KCl-stimulated RhoA activity in intrapulmonary arteries (C). A: dihydroethidium (DHE, 10 μmol/l) fluorescence [arbitrary units (AU)] as a function of time in pressurized, endothelium-disrupted, Ca2+-permeabilized arteries from control and CH rats (n = 5 per group for each treatment) in the presence of vehicle or tiron (10 mmol/l). Horizontal bar indicates addition of KCl (60 mmol/l). B: mean baseline and KCl-stimulated DHE fluorescence for control and CH arteries in the presence of vehicle or tiron. C: representative images of Western blots for GTP-bound (activated) RhoA and mean densitometric data for GTP-bound RhoA normalized to total RhoA in homogenates of intrapulmonary arteries from control (C) and CH rats (n = 5 per group for each treatment) in the presence of KCl (60 mmol/l) + tiron (10 mmol/l) or KCl (60 mmol/l) + vehicle. Values are means ± SE. *P < 0.05 vs. control vehicle. #P < 0.05 vs. CH vehicle. †P < 0.05 vs. baseline.

Contribution of O2 to KCl-Stimulated RhoA Activity in Pulmonary Arteries

We next sought to further define the relationship between O2 and RhoA activation following CH by assessing effects of tiron on KCl-induced RhoA activation in pulmonary arteries from control and CH rats. In accordance with the inhibitory influence of O2 scavenging on ROCK-dependent myofilament Ca2+ sensitization in CH arteries (Fig. 7C), tiron abolished the KCl-induced elevation of GTP-bound RhoA in pulmonary arteries from CH rats but had no effect in control arteries (Fig. 8C). These results provide direct evidence that depolarization-induced O2 generation elicits RhoA activation.

DISCUSSION

The major findings of this study are as follows: 1) Em depolarization mediates constriction of small pulmonary arteries through a novel Ca2+-independent signaling pathway in VSM; 2) CH augments depolarization-induced myofilament Ca2+ sensitization through stimulation of RhoA/ROCK; 3) CH increases O2 generation in response to KCl in small pulmonary arteries; and 4) O2 mediates depolarization-dependent RhoA activation through a mechanism that does not involve Ca2+ as a second messenger. Collectively, these results indicate that CH increases Em depolarization-induced Ca2+ sensitization in pulmonary VSM through O2-dependent activation of the RhoA/ROCK signaling cascade.

Studies of chronic ROCK inhibition reveal a major contribution of this enzyme to the development of pulmonary hypertension (9, 16). Furthermore, acute reversal of pulmonary arterial pressure and total pulmonary resistance following administration of ROCK inhibitors in CH rats (32, 34) suggests that vasoconstrictor responses involving ROCK signaling are of primary importance in mediating CH-induced pulmonary hypertension. Recent studies have begun to address the component mechanisms of this vasoconstriction, revealing that CH enhances spontaneous arterial tone and vasoconstriction to receptor-mediated agonists through a ROCK-dependent Ca2+ sensitization pathway in pulmonary VSM (2, 3, 20, 34, 54).

In addition to its role in augmentation of basal and agonist-induced vasoconstriction, CH has been demonstrated to increase reactivity to depolarizing concentrations of KCl (2, 14, 34), although this is not a universal finding (35, 42). We have confirmed that CH enhances KCl-dependent vasoconstriction in isolated perfused lungs. However, consistent with earlier results from endothelium-intact pulmonary arteries (35), KCl-dependent increases in pulmonary VSM [Ca2+]i were markedly blunted after CH in endothelium-disrupted arteries. Although the mechanism by which CH impairs K+-mediated increases in VSM [Ca2+]i is not clear, these findings nevertheless implicate myofilament Ca2+ sensitization in mediating vasoconstriction to a depolarizing stimulus in hypertensive arteries.

A contribution of ROCK to depolarization-induced vasoconstriction after CH is supported by our findings that HA-1077 markedly blunted responsiveness to KCl in isolated lungs as well as pulmonary arteries from CH animals. Although we cannot exclude potential nonspecific actions of HA-1077 in this preparation, the specificity of this compound at the concentration used in the present study (10 μmol/l) is supported by evidence that the potency of HA-1077 for inhibition of ROCKI and ROCKII (IC50 = 1.2 and 0.82 μmol/l, respectively) is ∼30–100 times greater than for inhibition of PKC or MLC kinase (5, 26, 40, 49). Further supporting the specificity of HA-1077 for ROCK vs. PKC is our recent finding that 10 μmol/l HA-1077 does not alter vasoconstriction to the PKC agonist PMA in isolated pulmonary arteries (3). Inhibitory effects of HA-1077 on depolarization-induced constriction in hypertensive pulmonary arteries are also consistent with our finding that KCl preferentially activates RhoA in these same vessels, thus supporting a role for RhoA/ROCK signaling in the enhanced vasoconstrictor reactivity following CH.

In is noteworthy that KCl-dependent vasoconstriction was more sensitive to ROCK inhibition in isolated lungs than in endothelium-disrupted arteries in each group of rats. Potentiation of ROCK-mediated vasoconstriction to depolarizing stimuli by the epithelium may account for these differential responses between preparations and could explain our present findings that CH more potently augmented KCl-dependent vasoconstriction in isolated lungs than in endothelium-disrupted pulmonary arteries. Consistent with this possibility are previous studies indicating that vasoreactivity to KCl is attenuated by inhibitors of ROCK in isolated perfused lungs (9, 14, 34) and endothelium-intact arteries from CH rats (14, 34, 54), whereas no such inhibition was observed in endothelium-denuded vessels from these animals (2, 54). ROCK additionally contributes to endothelium-dependent contractions in rat aorta (4). Furthermore, Homma and colleagues (14) found that the augmented KCl-induced vasoconstriction in lungs from pulmonary hypertensive rats was reduced by endothelin or serotonin receptor antagonism, suggesting that endogenous endothelin-1 and serotonin mediate enhanced KCl-dependent Ca2+ sensitization following hypoxic acclimation. Nevertheless, our observation that HA-1077 attenuated reactivity to KCl in endothelium-disrupted arteries from CH, but not control, rats indicates that CH plays an additional role in the increase in depolarization-induced VSM Ca2+ sensitization through a mechanism inherent to the VSM. Therefore, the major objective of the present study was to evaluate VSM signaling mechanisms responsible for this induction of ROCK-mediated vasoconstriction following CH.

Whereas RhoA stimulation in VSM is well established to occur secondary to activation of G protein-coupled receptors (45), ROCK-mediated VSM Ca2+ sensitization can also be elicited by depolarizing stimuli (33, 41, 50), presumably via Ca2+-dependent stimulation of RhoA (33, 41, 50) (i.e., Ca2+-induced Ca2+ sensitization). However, depolarization has been demonstrated to activate this pathway via a novel Ca2+-independent mechanism in renal tubular epithelium (46). In the present study, we addressed the hypothesis that a similar mechanism of RhoA activation exists in VSM that contributes to enhanced depolarization-induced pulmonary vasoconstriction following CH. We tested this hypothesis by assessing KCl-mediated constriction in arteries in which VSM [Ca2+]i had been clamped with the Ca2+ ionophore ionomycin (20). This approach eliminates any contribution of Ca2+ mobilization/influx to depolarization-induced vasoconstriction and controls for previously reported effects of ROCK inhibitors to lower VSM [Ca2+]i (53). Our finding that KCl elicited constriction in Ca2+-permeabilized arteries provides direct support for membrane depolarization-induced vasoconstriction independent of changes in VSM [Ca2+]i. In addition, this response to KCl was greater in CH than control arteries, indicating that CH augments depolarization-mediated vasoconstriction through a previously undescribed Ca2+-independent signaling pathway in VSM. Whereas this response to depolarization was independent of ROCK in normotensive pulmonary arteries, HA-1077-mediated attenuation of KCl-dependent vasoconstriction and normalization of reactivity between vessels from normoxic and CH rats demonstrate a primary role for ROCK signaling in enhanced depolarization-induced vasoconstriction following CH. Interestingly, substantial vasoconstriction remained after ROCK or PKC inhibition in both groups, suggesting that additional Ca2+ sensitization pathways (13) or, perhaps, actin polymerization (12) contributes to depolarization-dependent constriction in the pulmonary circulation. However, inasmuch as we cannot be certain that GF-109203X effectively inhibited all isoforms of PKC, we cannot exclude a potential role for PKC-dependent Ca2+ sensitization in mediating the persistent vasoconstriction in the presence of GF-109203X or HA-1077. RhoA activity assays in Ca2+-permeabilized arteries provided direct evidence that CH promotes Ca2+-independent, depolarization-induced RhoA activation. Although such RhoA activation could result from L-type Ca2+ channels acting as metabotropic receptors linking depolarization to stimulation of a heterotrimeric G protein, as described in basilar arterial myocytes (51), this is not a likely explanation, since L-type Ca2+ channel inhibition was without effect on KCl-mediated Ca2+ sensitization in the present study. Collectively, our present observations demonstrate that CH increases depolarization-induced Ca2+ sensitization in pulmonary VSM through stimulation of RhoA signaling. Furthermore, activation of RhoA by membrane depolarization can occur through a distinct Ca2+-independent mechanism in hypertensive arteries, similar to that previously described in renal tubular epithelial cells (46). If we consider that isolated pulmonary arteries exhibit pressure-dependent depolarization that is augmented following CH (35), such a mechanism of depolarization-induced RhoA activation could contribute to the ROCK-dependent myogenicity observed in these vessels (3).

Although ROS generation has been reported to be reduced in isolated lungs from CH rats (37), substantial evidence supports a contribution of ROS to enhanced agonist-mediated pulmonary vasoconstriction and pulmonary hypertension following CH (8, 11, 15, 20, 27). However, few studies have investigated a potential link between ROS and VSM Ca2+ sensitivity in this response. This idea is supported by evidence that O2 mediates ROCK-dependent VSM contraction in ductus arteriosus (22), aorta (21), and pulmonary arteries (20, 24). Furthermore, a mechanistic relationship between endothelin receptor stimulation, O2 generation, and RhoA-induced myofilament Ca2+ sensitization was recently demonstrated in hypertensive rat pulmonary arteries (20). Depolarizing stimuli have additionally been associated with increased ROS generation in endothelial cells, macula densa, and isolated mouse and rat lungs (1, 44). Thus it is feasible that O2 functions as an intracellular second messenger linking pulmonary VSM depolarization to RhoA activation and associated vasoconstriction.

The effect of CH in promotion of depolarization-dependent O2 generation in the present study appears to be a key determinant of enhanced pulmonary VSM Ca2+ sensitivity and associated vasoconstriction following CH, since the O2-specific spin trap tiron selectively attenuated KCl-induced vasoconstriction in isolated lungs and Ca2+-clamped pulmonary arteries from CH rats. Although the effect of tiron to inhibit vasoconstriction in isolated lungs from CH rats could reflect an increase in NO bioavailability by limiting O2-dependent NO scavenging, this seems unlikely, when we consider that a similar response was not observed in control lungs and that tiron has no effect on endothelium-derived NO-dependent vasodilation in isolated lungs from control or CH rats ventilated with normoxic gas (18). Our finding that the combination of O2 and ROCK did not provide greater inhibition of KCl-dependent reactivity than scavenging of O2 alone provides additional evidence that O2 signals in series with RhoA/ROCK to increase myofilament Ca2+ sensitivity in CH arteries. The causal link between depolarization-induced O2 generation and RhoA stimulation is demonstrated by the effect of tiron to selectively abolish the KCl-dependent elevation of RhoA activity in pulmonary arteries from CH rats. However, the distal signaling mechanisms by which O2-dependent RhoA activation leads to vasoconstriction remain to be established. Whereas RhoA may signal through the well-established pathway of ROCK-dependent inhibition of MLC phosphatase, it is additionally possible that this response is mediated by direct effects of ROCK to phosphorylate the MLC or, rather, to activate other Ca2+-independent MLC kinases, including ZIP kinase or integrin-linked kinase, to increase myofilament Ca2+ sensitivity (13). An alternative possibility is that RhoA activation promotes actin polymerization and the formation of stress fibers to mediate contraction (12) and, thus, does not represent a classical Ca2+ sensitization phenomenon. Although this study also does not address whether O2 per se or, rather, a product of O2 metabolism (e.g., H2O2 or hydroxyl radical) is directly responsible for RhoA activation, earlier studies have indicated an exclusive role for O2 in this response (21, 24). These results, together with data from Ca2+-permeabilized arteries and DHE experiments, support a novel link between membrane depolarization, O2 generation, and RhoA/ROCK signaling that mediates enhanced myofilament Ca2+ sensitivity in the hypertensive pulmonary circulation. These findings may additionally establish a mechanistic basis for previous studies that have established a crucial role for ROS in the development of hypoxic pulmonary hypertension (8, 15).

Our present finding that CH causes basal Em depolarization in endothelium-disrupted, Ca2+-permeabilized pulmonary arteries is consistent with previous results from isolated, endothelium-intact arteries (35) and isolated pulmonary arterial myocytes (36, 42, 43). Interestingly, we found that this separation of VSM Em between control and CH vessels persisted with increasing concentrations of KCl, presumably because of decreased membrane K+ permeability associated with downregulation of VSM K+ channels following CH (36, 37). Although these results may account for greater depolarization-induced VSM Ca2+ sensitization following CH, an additional possibility is that CH augments KCl-induced vasoconstriction for a given level of Em. Indeed, our observation that KCl increased DHE fluorescence only in CH arteries suggests that the mechanism linking depolarization to O2 generation and RhoA activation is not functional in control tissue but, rather, reflects a pathophysiological response to CH. Whether this mechanism results from an increase in expression or functional coupling of a O2-generating enzyme to Em or, rather, a reduction of antioxidant system activity (e.g., superoxide dismutase) remains to be determined.

In conclusion, this study establishes a novel signaling axis involving Ca2+-independent Em depolarization and O2-induced activation of the RhoA/ROCK pathway in pulmonary VSM. Future studies will be aimed at identifying the contribution of depolarization-induced ROS generation to myogenic and receptor-mediated vasoconstriction in the hypertensive pulmonary vasculature, establishing the source(s) of O2 that mediates enhanced RhoA-dependent Ca2+ sensitization following CH, and determining the signaling mechanism linking membrane depolarization to RhoA stimulation. Such a mechanism may involve the influence of CH on the activity or cellular trafficking of components of the ROS-RhoA signaling axis through alterations in the composition of signaling platforms within the lipid bilayer or possible effects of Em to directly regulate enzymatic activity of relevant second messengers. The concept of depolarization as a Ca2+-independent effector of ROS signaling has potentially broad physiological implications for not only RhoA-induced VSM contraction, but also for regulation of cytoskeletal organization, motility, proliferation, and apoptosis in pulmonary hypertension.

GRANTS

This work was supported by National Heart, Lung, and Blood Institute Grants HL-92598 (N. L. Jernigan), HL-77876 and HL-88192 (T. C. Resta), and HL-58124 and HL-07736 (B. R. Walker) and American Heart Association Grants 0755775Z (T. C. Resta) and 0625647Z (B. R. S. Broughton).

DISCLOSURES

No conflicts of interest are declared by the authors.

Supplementary Material

[Supplemental Figures and Tables]
00276.2009_index.html (1,008B, html)

ACKNOWLEDGMENTS

We thank Minerva Murphy for technical assistance.

Current affiliation of B. R. S. Broughton: Department of Pharmacology, Monash University, Clayton 3800, Victoria, Australia.

REFERENCES

  • 1.Al Mehdi AB, Zhao G, Dodia C, Tozawa K, Costa K, Muzykantov V, Ross C, Blecha F, Dinauer M, Fisher AB. Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+. Circ Res 83: 730–737, 1998 [DOI] [PubMed] [Google Scholar]
  • 2.Barman SA. Vasoconstrictor effect of endothelin-1 on hypertensive pulmonary arterial smooth muscle involves Rho-kinase and protein kinase C. Am J Physiol Lung Cell Mol Physiol 293: L472–L479, 2007 [DOI] [PubMed] [Google Scholar]
  • 3.Broughton BR, Walker BR, Resta TC. Chronic hypoxia induces Rho kinase-dependent myogenic tone in small pulmonary arteries. Am J Physiol Lung Cell Mol Physiol 294: L797–L806, 2008 [DOI] [PubMed] [Google Scholar]
  • 4.Chan CK, Mak JC, Man RY, Vanhoutte PM. Rho kinase inhibitors prevent endothelium-dependent contractions in the rat aorta. J Pharmacol Exp Ther 329: 820–826, 2009 [DOI] [PubMed] [Google Scholar]
  • 5.Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95–105, 2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Dikalov S, Griendling KK, Harrison DG. Measurement of reactive oxygen species in cardiovascular studies. Hypertension 49: 717–727, 2007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Earley S, Resta TC, Walker BR. Disruption of smooth muscle gap junctions attenuates myogenic vasoconstriction of mesenteric resistance arteries. Am J Physiol Heart Circ Physiol 287: H2677–H2686, 2004 [DOI] [PubMed] [Google Scholar]
  • 8.Elmedal B, de Dam MY, Mulvany MJ, Simonsen U. The superoxide dismutase mimetic, tempol, blunts right ventricular hypertrophy in chronic hypoxic rats. Br J Pharmacol 141: 105–113, 2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Fagan KA, Oka M, Bauer NR, Gebb SA, Ivy DD, Morris KG, McMurtry IF. Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase. Am J Physiol Lung Cell Mol Physiol 287: L656–L664, 2004 [DOI] [PubMed] [Google Scholar]
  • 10.Feddersen CO, Chang S, Czartalomna J, Voelkel NF. Arachidonic acid causes cyclooxygenase-dependent and -independent pulmonary vasodilation. J Appl Physiol 68: 1799–1808, 1990 [DOI] [PubMed] [Google Scholar]
  • 11.Fike CD, Slaughter JC, Kaplowitz MR, Zhang Y, Aschner JL. Reactive oxygen species from NADPH oxidase contribute to altered pulmonary vascular responses in piglets with chronic hypoxia-induced pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 295: L881–L888, 2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Gunst SJ, Zhang W. Actin cytoskeletal dynamics in smooth muscle: a new paradigm for the regulation of smooth muscle contraction. Am J Physiol Cell Physiol 295: C576–C587, 2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Hirano K. Current topics in the regulatory mechanism underlying the Ca2+ sensitization of the contractile apparatus in vascular smooth muscle. J Pharm Sci 104: 109–115, 2007 [DOI] [PubMed] [Google Scholar]
  • 14.Homma N, Nagaoka T, Morio Y, Ota H, Gebb SA, Karoor V, McMurtry IF, Oka M. Endothelin-1 and serotonin are involved in activation of RhoA/Rho kinase signaling in the chronically hypoxic hypertensive rat pulmonary circulation. J Cardiovasc Pharmacol 50: 697–702, 2007 [DOI] [PubMed] [Google Scholar]
  • 15.Hoshikawa Y, Ono S, Suzuki S, Tanita T, Chida M, Song C, Noda M, Tabata T, Voelkel NF, Fujimura S. Generation of oxidative stress contributes to the development of pulmonary hypertension induced by hypoxia. J Appl Physiol 90: 1299–1306, 2001 [DOI] [PubMed] [Google Scholar]
  • 16.Hyvelin JM, Howell K, Nichol A, Costello CM, Preston RJ, McLoughlin P. Inhibition of Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation. Circ Res 97: 185–191, 2005 [DOI] [PubMed] [Google Scholar]
  • 17.Jernigan NL, Broughton BR, Walker BR, Resta TC. Impaired NO-dependent inhibition of store- and receptor-operated calcium entry in pulmonary vascular smooth muscle after chronic hypoxia. Am J Physiol Lung Cell Mol Physiol 290: L517–L525, 2006 [DOI] [PubMed] [Google Scholar]
  • 18.Jernigan NL, Resta TC, Walker BR. Contribution of oxygen radicals to altered NO-dependent pulmonary vasodilation in acute and chronic hypoxia. Am J Physiol Lung Cell Mol Physiol 286: L947–L955, 2004 [DOI] [PubMed] [Google Scholar]
  • 19.Jernigan NL, Walker BR, Resta TC. Chronic hypoxia augments protein kinase G-mediated Ca2+ desensitization in pulmonary vascular smooth muscle through inhibition of RhoA/Rho kinase signaling. Am J Physiol Lung Cell Mol Physiol 287: L1220–L1229, 2004 [DOI] [PubMed] [Google Scholar]
  • 20.Jernigan NL, Walker BR, Resta TC. Reactive oxygen species mediate RhoA/Rho kinase-induced Ca2+ sensitization in pulmonary vascular smooth muscle following chronic hypoxia. Am J Physiol Lung Cell Mol Physiol 295: L515–L529, 2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Jin L, Ying Z, Webb RC. Activation of Rho/Rho kinase signaling pathway by reactive oxygen species in rat aorta. Am J Physiol Heart Circ Physiol 287: H1495–H1500, 2004 [DOI] [PubMed] [Google Scholar]
  • 22.Kajimoto H, Hashimoto K, Bonnet SN, Haromy A, Harry G, Moudgil R, Nakanishi T, Rebeyka I, Thebaud B, Michelakis ED, Archer SL. Oxygen activates the Rho/Rho-kinase pathway and induces RhoB and ROCK-1 expression in human and rabbit ductus arteriosus by increasing mitochondria-derived reactive oxygen species: a newly recognized mechanism for sustaining ductal constriction. Circulation 115: 1777–1788, 2007 [DOI] [PubMed] [Google Scholar]
  • 24.Knock GA, Snetkov VA, Shaifta Y, Connolly M, Drndarski S, Noah A, Pourmahram GE, Becker S, Aaronson PI, Ward JP. Superoxide constricts rat pulmonary arteries via Rho-kinase-mediated Ca2+ sensitization. Free Radic Biol Med 46: 633–642, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Ledenev AN, Konstantinov AA, Popova E, Ruuge EK. A simple assay of the superoxide generation rate with Tiron as an EPR-visible radical scavenger. Biochem Int 13: 391–396, 1986 [PubMed] [Google Scholar]
  • 26.Liao JK, Seto M, Noma K. Rho kinase (ROCK) inhibitors. J Cardiovasc Pharmacol 50: 17–24, 2007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Liu JQ, Zelko IN, Erbynn EM, Sham JS, Folz RJ. Hypoxic pulmonary hypertension: role of superoxide and NADPH oxidase (gp91phox). Am J Physiol Lung Cell Mol Physiol 290: L2–L10, 2006 [DOI] [PubMed] [Google Scholar]
  • 28.Liu R, Garvin JL, Ren Y, Pagano PJ, Carretero OA. Depolarization of the macula densa induces superoxide production via NAD(P)H oxidase. Am J Physiol Renal Physiol 292: F1867–F1872, 2007 [DOI] [PubMed] [Google Scholar]
  • 29.Luykenaar KD, Brett SE, Wu BN, Wiehler WB, Welsh DG. Pyrimidine nucleotides suppress KDR currents and depolarize rat cerebral arteries by activating Rho kinase. Am J Physiol Heart Circ Physiol 286: H1088–H1100, 2004 [DOI] [PubMed] [Google Scholar]
  • 30.Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marme D, Schachtele C. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 268: 9194–9197, 1993 [PubMed] [Google Scholar]
  • 31.McMurtry IF, Petrun MD, Reeves JT. Lungs from chronically hypoxic rats have decreased pressor response to acute hypoxia. Am J Physiol Heart Circ Physiol 235: H104–H109, 1978 [DOI] [PubMed] [Google Scholar]
  • 32.McNamara PJ, Murthy P, Kantores C, Teixeira L, Engelberts D, van Vliet T, Kavanagh BP, Jankov RP. Acute vasodilator effects of Rho-kinase inhibitors in neonatal rats with pulmonary hypertension unresponsive to nitric oxide. Am J Physiol Lung Cell Mol Physiol 294: L205–L213, 2008 [DOI] [PubMed] [Google Scholar]
  • 33.Mita M, Yanagihara H, Hishinuma S, Saito M, Walsh MP. Membrane depolarization-induced contraction of rat caudal arterial smooth muscle involves Rho-associated kinase. Biochem J 364: 431–440, 2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Nagaoka T, Morio Y, Casanova N, Bauer N, Gebb S, McMurtry I, Oka M. Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats. Am J Physiol Lung Cell Mol Physiol 287: L665–L672, 2004 [DOI] [PubMed] [Google Scholar]
  • 35.Naik JS, Earley S, Resta TC, Walker BR. Pressure-induced smooth muscle cell depolarization in pulmonary arteries from control and chronically hypoxic rats does not cause myogenic vasoconstriction. J Appl Physiol 98: 1119–1124, 2005 [DOI] [PubMed] [Google Scholar]
  • 36.Platoshyn O, Yu Y, Golovina VA, McDaniel SS, Krick S, Li L, Wang JY, Rubin LJ, Yuan JX. Chronic hypoxia decreases KV channel expression and function in pulmonary artery myocytes. Am J Physiol Lung Cell Mol Physiol 280: L801–L812, 2001 [DOI] [PubMed] [Google Scholar]
  • 37.Reeve HL, Michelakis E, Nelson DP, Weir EK, Archer SL. Alterations in a redox oxygen sensing mechanism in chronic hypoxia. J Appl Physiol 90: 2249–2256, 2001 [DOI] [PubMed] [Google Scholar]
  • 38.Resta TC, Chicoine LG, Omdahl JL, Walker BR. Maintained upregulation of pulmonary eNOS gene and protein expression during recovery from chronic hypoxia. Am J Physiol Heart Circ Physiol 276: H699–H708, 1999 [DOI] [PubMed] [Google Scholar]
  • 39.Resta TC, Walker BR. Chronic hypoxia selectively augments endothelium-dependent pulmonary arterial vasodilation. Am J Physiol Heart Circ Physiol 270: H888–H896, 1996 [DOI] [PubMed] [Google Scholar]
  • 40.Rikitake Y, Kim HH, Huang Z, Seto M, Yano K, Asano T, Moskowitz MA, Liao JK. Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection. Stroke 36: 2251–2257, 2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Sakurada S, Takuwa N, Sugimoto N, Wang Y, Seto M, Sasaki Y, Takuwa Y. Ca2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction. Circ Res 93: 548–556, 2003 [DOI] [PubMed] [Google Scholar]
  • 42.Shimoda LA, Sham JS, Shimoda TH, Sylvester JT. L-type Ca2+ channels, resting [Ca2+]i, and ET-1-induced responses in chronically hypoxic pulmonary myocytes. Am J Physiol Lung Cell Mol Physiol 279: L884–L894, 2000 [DOI] [PubMed] [Google Scholar]
  • 43.Smirnov SV, Robertson TP, Ward JP, Aaronson PI. Chronic hypoxia is associated with reduced delayed rectifier K+ current in rat pulmonary artery muscle cells. Am J Physiol Heart Circ Physiol 266: H365–H370, 1994 [DOI] [PubMed] [Google Scholar]
  • 44.Sohn HY, Keller M, Gloe T, Morawietz H, Rueckschloss U, Pohl U. The small G-protein Rac mediates depolarization-induced superoxide formation in human endothelial cells. J Biol Chem 275: 18745–18750, 2000 [DOI] [PubMed] [Google Scholar]
  • 45.Somlyo AP, Somlyo AV. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83: 1325–1358, 2003 [DOI] [PubMed] [Google Scholar]
  • 46.Szaszi K, Sirokmany G, Ciano-Oliveira C, Rotstein OD, Kapus A. Depolarization induces Rho-Rho kinase-mediated myosin light chain phosphorylation in kidney tubular cells. Am J Physiol Cell Physiol 289: C673–C685, 2005 [DOI] [PubMed] [Google Scholar]
  • 47.Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266: 15771–15781, 1991 [PubMed] [Google Scholar]
  • 49.Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, Narumiya S. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389: 990–994, 1997 [DOI] [PubMed] [Google Scholar]
  • 50.Urban NH, Berg KM, Ratz PH. K+ depolarization induces RhoA kinase translocation to caveolae and Ca2+ sensitization of arterial muscle. Am J Physiol Cell Physiol 285: C1377–C1385, 2003 [DOI] [PubMed] [Google Scholar]
  • 51.Valle-Rodriguez A, Lopez-Barneo J, Urena J. Ca2+ channel-sarcoplasmic reticulum coupling: a mechanism of arterial myocyte contraction without Ca2+ influx. EMBO J 22: 4337–4345, 2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Walker BR, Resta TC, Nelin LD. Nitric oxide-dependent pulmonary vasodilation in polycythemic rats. Am J Physiol Heart Circ Physiol 279: H2382–H2389, 2000 [DOI] [PubMed] [Google Scholar]
  • 53.Wang J, Weigand L, Foxson J, Shimoda LA, Sylvester JT. Ca2+ signaling in hypoxic pulmonary vasoconstriction: effects of myosin light chain and Rho kinase antagonists. Am J Physiol Lung Cell Mol Physiol 293: L674–L685, 2007 [DOI] [PubMed] [Google Scholar]
  • 54.Weigand L, Sylvester JT, Shimoda LA. Mechanisms of endothelin-1-induced contraction in pulmonary arteries from chronically hypoxic rats. Am J Physiol Lung Cell Mol Physiol 290: L284–L290, 2006 [DOI] [PubMed] [Google Scholar]
  • 55.Woodsome TP, Polzin A, Kitazawa K, Eto M, Kitazawa T. Agonist- and depolarization-induced signals for myosin light chain phosphorylation and force generation of cultured vascular smooth muscle cells. J Cell Sci 119: 1769–1780, 2006 [DOI] [PubMed] [Google Scholar]
  • 56.Wu W, Platoshyn O, Firth AL, Yuan JX. Hypoxia divergently regulates production of reactive oxygen species in human pulmonary and coronary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 293: L952–L959, 2007 [DOI] [PubMed] [Google Scholar]
  • 57.Zhao H, Kalivendi S, Zhang H, Joseph J, Nithipatikom K, Vasquez-Vivar J, Kalyanaraman B. Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: potential implications in intracellular fluorescence detection of superoxide. Free Radic Biol Med 34: 1359–1368, 2003 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Supplemental Figures and Tables]
00276.2009_index.html (1,008B, html)
00276.2009_1.pdf (53.5KB, pdf)

Articles from American Journal of Physiology - Lung Cellular and Molecular Physiology are provided here courtesy of American Physiological Society

RESOURCES